surpass tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes SURPASS-CVOT Published: Large Trial Confirms

Higher efficacy ceiling: Next-generation multi-agonists, led by triple-agonists like Retatrutide, are pushing weight-loss projections up to 30% while maintaining manageable side-effect profiles

A medication that reduces alcohol consumption might offset its own cost through reduced spending on alcohol, reduced healthcare utilization for alcohol-related conditions, and improved work productivity

Spotting between periods Light bleeding outside of the usual cycle has also been mentioned

Those expanding ice crystals tear through the delicate three-dimensional structure that semaglutide needs to bind to GLP-1 receptors

Stomach: Slows gastric emptying, so food stays in the stomach longer